Cyanotech Corp

Aloha from Kona, Hawaii. Thank you all for joining us today. I'm Jerry Susoski, Chief Executive Officer of Cyanotech. Joining me on the call today is Felicia Layden, our Chief Financial Officer. I am pleased to report Cyanotech's third quarter fiscal year 2022 earnings results. I will turn the call over to Felicia to provide our forward-looking statement.

Thanks, Jerry. Our discussion today may include forward-looking statements. We do not undertake any obligation to update forward-looking statements either as a result of new information, future events, or otherwise. Our actual results may differ materially from what is described in these forward-looking statements. Some of the factors that may cause results to differ are listed in our publicly filed documents. For additional information, we encourage you to review our 10Q and fiscal year 2021 10K report filed with the Securities and Exchange Commission. I will turn it back to Jerry for comments on the quarter. Jerry?

The financial results for the third quarter of fiscal year 2022 continue the positive results from the last two quarters of fiscal year 2022. Although we are experiencing supply chain constraints similar to most production and manufacturing businesses, we have been able to minimize them to date. Demand remains strong as we are benefiting from increased interest in naturally derived high-value nutritional products for human health and well-being. During the third quarter, we paid off the outstanding balance on the line of credit of $350,000. This provides us with additional liquidity and access to the full $2 million on the line of credit. Now I would like to turn the call over to Felicia to discuss the third quarter. Felicia, please.